Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.36
-0.11 (-1.70%)
At close: Mar 9, 2026, 4:00 PM EDT
6.11
-0.25 (-3.99%)
After-hours: Mar 9, 2026, 4:25 PM EDT

Company Description

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories.

It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Inogen, Inc.
Inogen logo
Country United States
Founded 2001
IPO Date Feb 14, 2014
Industry Medical Devices
Sector Healthcare
Employees 766
CEO Kevin R. Smith

Contact Details

Address:
500 Cummings Center, Suite 2800
Beverly, Massachusetts 01915
United States
Phone 805 562 0500
Website provider.inogen.com

Stock Details

Ticker Symbol INGN
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001294133
CUSIP Number 45780L104
ISIN Number US45780L1044
SIC Code 3842

Key Executives

Name Position
Kevin R. M. Smith President, Chief Executive Officer and Director
Michael J. Bourque CPA Executive Vice President, Chief Financial Officer and Corporate Treasurer
Kevin P. Smith General Counsel, Secretary and Executive Vice President of Business Development
Grgoire Ramade Executive Vice President and Chief Commercial Officer
Philip Corrin Senior Vice President of Operations and Supply Chain
Mary Wright Chief Accounting Officer
Naga Rameswamy Chief Technology Officer
Lorna Williams Senior Vice President of Investor Relations
Jennifer Yi Boyer Executive Vice President of Enterprise Enablement and Chief Human Resources Officer
Dr. Krishna Jhaveri Chief Medical Officer

Latest SEC Filings

Date Type Title
Feb 27, 2026 S-8 Securities to be offered to employees in employee benefit plans
Feb 27, 2026 10-K Annual Report
Feb 24, 2026 8-K Current Report
Jan 12, 2026 8-K Current Report
Nov 6, 2025 10-Q Quarterly Report
Nov 5, 2025 8-K Current Report
Aug 8, 2025 10-Q Quarterly Report
Aug 7, 2025 8-K Current Report
Jul 29, 2025 8-K Current Report
Jul 17, 2025 SCHEDULE 13G/A Filing